One in nine people over the age of 65 suffer from Alzheimer’s disease – colloquially known as “the long goodbye” – and the University of South...
Alzamend Neuro, a Tampa biopharmaceutical firm focused on developing products to treat neurodegenerative diseases and psychiatric disorders, could become the area’s next publicly traded company. Alzamend...
Your eyes may hold the key to detecting early signs of Alzheimer’s disease. That’s the idea behind a $5 million, five-year study backed by BayCare Health...
